Advisors Asset Management Inc. Raises Stock Holdings in Sabra Healthcare REIT, Inc. $SBRA

Key Points

• Advisors Asset Management Inc. increased its position in Sabra Healthcare REIT by 10.6%, owning approximately $3.09 million worth of the stock as of the latest SEC filing.
• Multiple analysts have upgraded their target prices for Sabra Healthcare REIT, with current estimates ranging from $20.00 to $22.00, reflecting a generally positive outlook.
• Sabra Healthcare REIT recently announced a quarterly dividend of $0.30, translating to an annualized yield of 6.3%.

Advisors Asset Management Inc. lifted its holdings in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report) by 10.6% during the 1st quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 176,877 shares of the real estate investment trust's stock after acquiring an additional 16,886 shares during the period. Advisors Asset Management Inc. owned 0.07% of Sabra Healthcare REIT worth $3,090,000 at the end of the most recent reporting period.

Several other institutional investors also recently added to or reduced their stakes in SBRA. Nuveen LLC acquired a new position in Sabra Healthcare REIT during the first quarter worth approximately $61,791,000. Jefferies Financial Group Inc. increased its position in Sabra Healthcare REIT by 7,196.8% during the first quarter. Jefferies Financial Group Inc. now owns 1,466,000 shares of the real estate investment trust's stock worth $25,611,000 after buying an additional 1,445,909 shares during the period. Universal Beteiligungs und Servicegesellschaft mbH acquired a new position in Sabra Healthcare REIT during the fourth quarter worth approximately $14,241,000. Wellington Management Group LLP increased its position in Sabra Healthcare REIT by 33.7% during the fourth quarter. Wellington Management Group LLP now owns 3,205,042 shares of the real estate investment trust's stock worth $55,511,000 after buying an additional 808,207 shares during the period. Finally, Nuveen Asset Management LLC increased its position in Sabra Healthcare REIT by 30.8% during the fourth quarter. Nuveen Asset Management LLC now owns 3,378,733 shares of the real estate investment trust's stock worth $58,520,000 after buying an additional 795,902 shares during the period. Institutional investors and hedge funds own 99.40% of the company's stock.

Sabra Healthcare REIT Price Performance

SBRA traded up $0.02 during trading on Thursday, reaching $18.95. 715,824 shares of the stock were exchanged, compared to its average volume of 2,436,480. The business's 50 day moving average price is $18.67 and its two-hundred day moving average price is $17.93. The company has a debt-to-equity ratio of 0.91, a current ratio of 4.80 and a quick ratio of 4.80. The company has a market capitalization of $4.54 billion, a price-to-earnings ratio of 24.94, a P/E/G ratio of 1.52 and a beta of 0.88. Sabra Healthcare REIT, Inc. has a 1 year low of $15.60 and a 1 year high of $20.03.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last posted its earnings results on Monday, August 4th. The real estate investment trust reported $0.38 EPS for the quarter, topping analysts' consensus estimates of $0.36 by $0.02. The company had revenue of $189.15 million for the quarter, compared to the consensus estimate of $185.64 million. Sabra Healthcare REIT had a return on equity of 6.69% and a net margin of 24.87%.Sabra Healthcare REIT's quarterly revenue was up 7.4% compared to the same quarter last year. During the same period in the previous year, the business earned $0.36 earnings per share. Sabra Healthcare REIT has set its FY 2025 guidance at 1.450-1.470 EPS. As a group, equities research analysts anticipate that Sabra Healthcare REIT, Inc. will post 1.45 earnings per share for the current year.

Sabra Healthcare REIT Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, August 29th. Shareholders of record on Friday, August 15th were given a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a yield of 6.3%. The ex-dividend date was Friday, August 15th. Sabra Healthcare REIT's payout ratio is presently 157.89%.

Wall Street Analyst Weigh In

SBRA has been the topic of a number of recent research reports. Wells Fargo & Company boosted their target price on Sabra Healthcare REIT from $20.00 to $21.00 and gave the company an "overweight" rating in a report on Wednesday, August 27th. Scotiabank boosted their target price on Sabra Healthcare REIT from $19.00 to $20.00 and gave the company a "sector perform" rating in a report on Monday, June 23rd. JMP Securities boosted their target price on Sabra Healthcare REIT from $20.00 to $22.00 and gave the company a "market outperform" rating in a report on Wednesday, August 6th. BMO Capital Markets boosted their target price on Sabra Healthcare REIT from $19.00 to $22.00 and gave the company a "market perform" rating in a report on Monday, August 25th. Finally, Truist Financial boosted their target price on Sabra Healthcare REIT from $18.00 to $20.00 and gave the company a "hold" rating in a report on Tuesday, September 2nd. One research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and four have issued a Hold rating to the company's stock. According to MarketBeat, the company has an average rating of "Moderate Buy" and an average price target of $20.71.

About Sabra Healthcare REIT

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.